Anticancer bioactivity of compounds from medicinal plants used in European medieval traditions

Biochemical Pharmacology

Volumn 86, Issue 9, 2013, Pages 1239-1247

  Teiten, Marie Hélène ^a   Gaascht, François ^a   Dicato, Mario ^a   Diederich, Marc ^b  

^a LABORATOIRE DE BIOLOGIE MOLÉCULAIRE ET CELLULAIRE DU CANCER   (Luxembourg)

^b Seoul National University   (South Korea)

Author keywords

Cancer hallmarks; Cell cycle; Cell death; Immune system; Inflammation signaling; Natural compounds; Tumor microenvironment

Indexed keywords

AJOENE; ALLICIN; ALLYL SULFIDE; ANTINEOPLASTIC AGENT; APIGENIN; ARCTIGENIN; CARNOSIC ACID; CARNOSOL; CROCIN; HELENALIN; HYPERFORIN; HYPERICIN; ISOLIQUIRITIGENIN; LICOCHALCONE A; PARTHENOLIDE; RESVERATROL; SILIBININ; SILYMARIN;

ANGIOGENESIS; ANTINEOPLASTIC ACTIVITY; ARCTIUM LAPPA; ARNICA MONTANA; ARTICLE; CALENDULA OFFICINALIS; CANCER CELL CULTURE; CANCER INHIBITION; CELL DEATH; CELL PROLIFERATION; CHINESE MEDICINE; CROCUS SATIVUS; GARLIC; GLYCYRRHIZA GLABRA; GRAPE; HUMAN; HYPERICUM PERFORATUM; IMMUNE RESPONSE; IMMUNOSTIMULATION; INFLAMMATION; MATRICARIA; MEDICINAL PLANT; NONHUMAN; PRIORITY JOURNAL; ROSEMARY; SILYBUM MARIANUM; TANACETUM PARTHENIUM;

EID: 84886719739     PISSN: 00062952     EISSN: 18732968     Source Type: Journal    
DOI: 10.1016/j.bcp.2013.08.007     Document Type: Note

References (94)

1. J.M. Riddle History as a tool in identifying new old drugs Adv Exp Med Biol 505 2002 89 94
2. P. De Vos European materia medica in historical texts: longevity of a tradition and implications for future use J Ethnopharmacol 132 2010 28 47
3. A. Karpozilos, and N. Pavlidis The treatment of cancer in Greek antiquity Eur J Cancer 40 2004 2033 2040
4. J. Mann Natural products in cancer chemotherapy: past, present and future Nat Rev Cancer 2 2002 143 148
5. M.H. Teiten, S. Eifes, M. Dicato, and M. Diederich Curcumin-the paradigm of a multi-target natural compound with applications in cancer prevention and treatment Toxins (Basel) 2 2010 128 162
6. B. Orlikova, and M. Diederich Power from the garden: plant compounds as inhibitors of the hallmarks of cancer Curr Med Chem 19 2012 2061 2087
7. W.R. Sawadogo, M. Schumacher, M.H. Teiten, M. Dicato, and M. Diederich Traditional West African pharmacopeia, plants and derived compounds for cancer therapy Biochem Pharmacol 84 2012 1225 1240
8. F. Watkins, B. Pendry, O. Corcoran, and A. Sanchez-Medina Anglo-Saxon pharmacopoeia revisited: a potential treasure in drug discovery Drug Discov Today 16 2011 1069 1075
9. C.C. Liolios, K. Graikou, E. Skaltsa, and I. Chinou Dittany of Crete: a botanical and ethnopharmacological review J Ethnopharmacol 131 2010 229 241
10. D. Hanahan, and R.A. Weinberg Hallmarks of cancer: the next generation Cell 144 2011 646 674
11. Y. Yarden, and A. Ullrich Growth factor receptor tyrosine kinases Annu Rev Biochem 57 1988 443 478
12. T. Mitsudomi, and Y. Yatabe Epidermal growth factor receptor in relation to tumor development: EGFR gene and cancer FEBS J 277 2010 301 308
13. D.L. McKay, and J.B. Blumberg A review of the bioactivity and potential health benefits of chamomile tea (Matricaria recutita L.) Phytother Res 20 2006 519 530
14. F. Yin, A.E. Giuliano, and A.J. Van Herle Signal pathways involved in apigenin inhibition of growth and induction of apoptosis of human anaplastic thyroid cancer cells (ARO) Anticancer Res 19 1999 4297 4303
15. L. Masuelli, L. Marzocchella, A. Quaranta, C. Palumbo, G. Pompa, and V. Izzi Apigenin induces apoptosis and impairs head and neck carcinomas EGFR/ErbB2 signaling Front Biosci 16 2011 1060 1068
16. K.M. Klemow, A. Bartlow, J. Crawford, N. Kocher, J. Shah, and M. Ritsick Medical attributes of St. John's Wort (Hypericum perforatum) I.F.F. Benzie, S. Wachtel-Galor, Herbal medicine: biomolecular and clinical aspects 2011 CRC Press Boca Raton (FL) (Chapter 11)
17. E.C. Tatsis, S. Boeren, V. Exarchou, A.N. Troganis, J. Vervoort, and I.P. Gerothanassis Identification of the major constituents of Hypericum perforatum by LC/SPE/NMR and/or LC/MS Phytochemistry 68 2007 383 393
18. K. Hostanska, J. Reichling, S. Bommer, M. Weber, and R. Saller Hyperforin a constituent of St John's wort (Hypericum perforatum L.) extract induces apoptosis by triggering activation of caspases and with hypericin synergistically exerts cytotoxicity towards human malignant cell lines Eur J Pharm Biopharm 56 2003 121 132
19. P. Agostinis, A. Vantieghem, W. Merlevede, and P.A. de Witte Hypericin in cancer treatment: more light on the way Int J Biochem Cell Biol 34 2002 221 241
20. J. Koval, J. Mikes, R. Jendzelovsky, M. Kello, P. Solar, and P. Fedorocko Degradation of HER2 receptor through hypericin-mediated photodynamic therapy Photochem Photobiol 86 2010 200 205
21. P. Solar, P. Ferenc, J. Koval, J. Mikes, Z. Solarova, and G. Hrckova Photoactivated hypericin induces downregulation of HER2 gene expression Radiat Res 2010
22. M. Provinciali, F. Re, A. Donnini, F. Orlando, B. Bartozzi, and G. Di Stasio Effect of resveratrol on the development of spontaneous mammary tumors in HER-2/neu transgenic mice Int J Cancer 115 2005 36 45
23. F.Y. Tang, E.P. Chiang, and Y.C. Sun Resveratrol inhibits heregulin-beta1-mediated matrix metalloproteinase-9 expression and cell invasion in human breast cancer cells J Nutr Biochem 19 2008 287 294
24. M. Canavese, L. Santo, and N. Raje Cyclin dependent kinases in cancer: potential for therapeutic intervention Cancer Biol Ther 13 2012 451 457
25. R. Boutros, V. Lobjois, and B. Ducommun CDC25 phosphatases in cancer cells: key players? Good targets Nat Rev Cancer 7 2007 495 507
26. F.J. Senorans, E. Ibanez, S. Cavero, J. Tabera, and G. Reglero Liquid chromatographic-mass spectrometric analysis of supercritical-fluid extracts of rosemary plants J Chromatogr A 870 2000 491 499
27. J.M. Visanji, D.G. Thompson, and P.J. Padfield Induction of G2/M phase cell cycle arrest by carnosol and carnosic acid is associated with alteration of cyclin A and cyclin B1 levels Cancer Lett 237 2006 130 136
28. R.S. Rivlin Historical perspective on the use of garlic J Nutr 131 2001 951S-4S
29. C. Cerella, M. Dicato, C. Jacob, and M. Diederich Chemical properties and mechanisms determining the anti-cancer action of garlic-derived organic sulfur compounds Anticancer Agents Med Chem 11 2011 267 271
30. K. Hirsch, M. Danilenko, J. Giat, T. Miron, A. Rabinkov, and M. Wilchek Effect of purified allicin, the major ingredient of freshly crushed garlic, on cancer cell proliferation Nutr Cancer 38 2000 245 254
31. M. Kelkel, C. Cerella, F. Mack, T. Schneider, C. Jacob, and M. Schumacher ROS-independent JNK activation and multisite phosphorylation of Bcl-2 link diallyl tetrasulfide-induced mitotic arrest to apoptosis Carcinogenesis 33 2012 2162 2171
32. E. Viry, A. Anwar, G. Kirsch, C. Jacob, M. Diederich, and D. Bagrel Antiproliferative effect of natural tetrasulfides in human breast cancer cells is mediated through the inhibition of the cell division cycle 25 phosphatases Int J Oncol 38 2011 1103 1111
33. 4) Apoptosis 14 2009 641 654
34. A.K. Joe, H. Liu, M. Suzui, M.E. Vural, D. Xiao, and I.B. Weinstein Resveratrol induces growth inhibition, S-phase arrest, apoptosis, and changes in biomarker expression in several human cancer cell lines Clin Cancer Res 8 2002 893 903
35. Y. Fu, T.C. Hsieh, J. Guo, J. Kunicki, M.Y. Lee, and Z. Darzynkiewicz Licochalcone-A, a novel flavonoid isolated from licorice root (Glycyrrhiza glabra), causes G2 and late-G1 arrests in androgen-independent PC-3 prostate cancer cells Biochem Biophys Res Commun 322 2004 263 270
36. C. Berges, D. Fuchs, G. Opelz, V. Daniel, and C. Naujokat Helenalin suppresses essential immune functions of activated CD4+ T cells by multiple mechanisms Mol Immunol 46 2009 2892 2901
37. G. Cheng, and L. Xie Parthenolide induces apoptosis and cell cycle arrest of human 5637 bladder cancer cells in vitro Molecules 16 2011 6758 6768
38. X. Fonrose, F. Ausseil, E. Soleilhac, V. Masson, B. David, and I. Pouny Parthenolide inhibits tubulin carboxypeptidase activity Cancer Res 67 2007 3371 3378
39. R. Kim, M. Emi, and K. Tanabe Cancer immunoediting from immune surveillance to immune escape Immunology 121 2007 1 14
40. D.L. Lamm, and D.R. Riggs Enhanced immunocompetence by garlic: role in bladder cancer and other malignancies J Nutr 131 2001 1067S-70S
41. M. Schink Mistletoe therapy for human cancer: the role of the natural killer cells Anticancer Drugs 8 Suppl 1 1997 S47-S51
42. S. Braedel-Ruoff Immunomodulatory effects of Viscum album extracts on natural killer cells: review of clinical trials Forsch Komplementmed 17 2010 63 73
43. C.C. Lu, and J.K. Chen Resveratrol enhances perforin expression and NK cell cytotoxicity through NKG2D-dependent pathways J Cell Physiol 223 2010 343 351
44. R. Falchetti, M.P. Fuggetta, G. Lanzilli, M. Tricarico, and G. Ravagnan Effects of resveratrol on human immune cell function Life Sci 70 2001 81 96
45. M. Daniel, G.W. Peek, and T.O. Tollefsbol Regulation of the human catalytic subunit of telomerase (hTERT) Gene 498 2012 135 146
46. S.K. Noureini, and M. Wink Antiproliferative effects of crocin in HepG2 cells by telomerase inhibition and hTERT down-regulation Asian Pac J Cancer Prev 13 2012 2305 2309
47. Z. Faezizadeh, S.A. Mesbah-Namin, and A. Allameh The effect of silymarin on telomerase activity in the human leukemia cell line K562 Planta Med 78 2012 899 902
48. P.R. Huang, Y.M. Yeh, and T.C. Wang Potent inhibition of human telomerase by helenalin Cancer Lett 227 2005 169 174
49. M. Kulis, and M. Esteller DNA methylation and cancer Adv Genet 70 2010 27 56
50. C. Sawan, and Z. Herceg Histone modifications and cancer Adv Genet 70 2010 57 85
51. H. Nian, B. Delage, J.T. Pinto, and R.H. Dashwood Allyl mercaptan, a garlic-derived organosulfur compound, inhibits histone deacetylase and enhances Sp3 binding on the P21WAF1 promoter Carcinogenesis 29 2008 1816 1824
52. R. Frazzi, R. Valli, I. Tamagnini, B. Casali, N. Latruffe, and F. Merli Resveratrol-mediated apoptosis of hodgkin lymphoma cells involves SIRT1 inhibition and FOXO3a hyperacetylation Int J Cancer 132 2013 1013 1021
53. S. Mirza, G. Sharma, R. Parshad, S.D. Gupta, P. Pandya, and R. Ralhan Expression of DNA methyltransferases in breast cancer patients and to analyze the effect of natural compounds on DNA methyltransferases and associated proteins J Breast Cancer 16 2013 23 31
54. Y.N. Gopal, T.S. Arora, and M.W. Van Dyke Parthenolide specifically depletes histone deacetylase 1 protein and induces cell death through ataxia telangiectasia mutated Chem Biol 14 2007 813 823
55. M. Pandey, P. Kaur, S. Shukla, A. Abbas, P. Fu, and S. Gupta Plant flavone apigenin inhibits HDAC and remodels chromatin to induce growth arrest and apoptosis in human prostate cancer cells: in vitro and in vivo study Mol Carcinog 51 2012 952 962
56. C.T. Mierke Physical break-down of the classical view on cancer cell invasion and metastasis Eur J Cell Biol 92 2013 89 104
57. G. Matysik, M. Wojciak-Kosior, and R. Paduch The influence of Calendulae officinalis flos extracts on cell cultures, and the chromatographic analysis of extracts J Pharm Biomed Anal 38 2005 285 292
58. K.C. Preethi, K.S. Siveen, R. Kuttan, and G. Kuttan Inhibition of metastasis of B16F-10 melanoma cells in C57BL/6 mice by an extract of Calendula officinalis L. flowers Asian Pac J Cancer Prev 11 2010 1773 1779
59. S.C. Huang, C.T. Ho, S.Y. Lin-Shiau, and J.K. Lin Carnosol inhibits the invasion of B16/F10 mouse melanoma cells by suppressing metalloproteinase-9 through down-regulating nuclear factor-kappa B and c-Jun Biochem Pharmacol 69 2005 221 232
60. M.V. Barni, M.J. Carlini, E.G. Cafferata, L. Puricelli, and S. Moreno Carnosic acid inhibits the proliferation and migration capacity of human colorectal cancer cells Oncol Rep 27 2012 1041 1048
61. X.W. Hu, D. Meng, and J. Fang Apigenin inhibited migration and invasion of human ovarian cancer A2780 cells through focal adhesion kinase Carcinogenesis 29 2008 2369 2376
62. C.A. Franzen, E. Amargo, V. Todorovic, B.V. Desai, S. Huda, and S. Mirzoeva The chemopreventive bioflavonoid apigenin inhibits prostate cancer cell motility through the focal adhesion kinase/Src signaling mechanism Cancer Prev Res (Phila) 2 2009 830 841
63. K.C. Lai, S.C. Hsu, C.L. Kuo, J.S. Yang, C.Y. Ma, and H.F. Lu Diallyl sulfide, diallyl disulfide, and diallyl trisulfide inhibit migration and invasion in human colon cancer colo 205 cells through the inhibition of matrix metalloproteinase-2, -7, and -9 expressions Environ Toxicol 2011
64. Q. Chu, M.T. Ling, H. Feng, H.W. Cheung, S.W. Tsao, and X. Wang A novel anticancer effect of garlic derivatives: inhibition of cancer cell invasion through restoration of E-cadherin expression Carcinogenesis 27 2006 2180 2189
65. C.Y. Sun, Y. Hu, T. Guo, H.F. Wang, X.P. Zhang, and W.J. He Resveratrol as a novel agent for treatment of multiple myeloma with matrix metalloproteinase inhibitory activity Acta Pharmacol Sin 27 2006 1447 1452
66. M. Dona, I. Dell'Aica, E. Pezzato, L. Sartor, F. Calabrese, and M. Della Barbera Hyperforin inhibits cancer invasion and metastasis Cancer Res 64 2004 6225 6232
67. K. Wu, J. Zeng, L. Li, J. Fan, D. Zhang, and Y. Xue Silibinin reverses epithelial-to-mesenchymal transition in metastatic prostate cancer cells by targeting transcription factors Oncol Rep 23 2010 1545 1552
68. P. Carmeliet, and R.K. Jain Molecular mechanisms and clinical applications of angiogenesis Nature 473 2011 298 307
69. S. Kim, J.H. Choi, H.I. Lim, S.K. Lee, W.W. Kim, and J.S. Kim Silibinin prevents TPA-induced MMP-9 expression and VEGF secretion by inactivation of the Raf/MEK/ERK pathway in MCF-7 human breast cancer cells Phytomedicine 16 2009 573 580
70. B. Martinez-Poveda, A.R. Quesada, and F Medina M.A. Hyperforin, a bio-active compound of St. John's Wort, is a new inhibitor of angiogenesis targeting several key steps of the process Int J Cancer 117 2005 775 780
71. C. Quiney, C. Billard, P. Mirshahi, J.D. Fourneron, and J.P. Kolb Hyperforin inhibits MMP-9 secretion by B-CLL cells and microtubule formation by endothelial cells Leukemia 20 2006 583 589
72. A. Lopez-Jimenez, M. Garcia-Caballero, M.A. Medina, and A.R. Quesada Anti-angiogenic properties of carnosol and carnosic acid, two major dietary compounds from rosemary Eur J Nutr 52 2013 85 95
73. P. Thejass, and G. Kuttan Antiangiogenic activity of Diallyl Sulfide (DAS) Int Immunopharmacol 7 2007 295 305
74. L. Ouyang, Z. Shi, S. Zhao, F.T. Wang, T.T. Zhou, and B. Liu Programmed cell death pathways in cancer: a review of apoptosis, autophagy and programmed necrosis Cell Prolif 45 2012 487 498
75. M.V. Jain, A.M. Paczulla, T. Klonisch, F.N. Dimgba, S.B. Rao, and K. Roberg Interconnections between apoptotic, autophagic and necrotic pathways: implications for cancer therapy development J Cell Mol Med 17 2013 12 29
76. W. Zhang, M. Ha, Y. Gong, Y. Xu, N. Dong, and Y. Yuan Allicin induces apoptosis in gastric cancer cells through activation of both extrinsic and intrinsic pathways Oncol Rep 24 2010 1585 1592
77. M. Zhao, J. Ma, H.Y. Zhu, X.H. Zhang, Z.Y. Du, and Y.J. Xu Apigenin inhibits proliferation and induces apoptosis in human multiple myeloma cells through targeting the trinity of CK2, Cdc37 and Hsp90 Mol Cancer 10 2011 104
78. H.F. Lu, Y.J. Chie, M.S. Yang, K.W. Lu, J.J. Fu, and J.S. Yang Apigenin induces apoptosis in human lung cancer H460 cells through caspase- and mitochondria-dependent pathways Hum Exp Toxicol 30 2011 1053 1061
79. J. Dorrie, K. Sapala, and S.J. Zunino Carnosol-induced apoptosis and downregulation of Bcl-2 in B-lineage leukemia cells Cancer Lett 170 2001 33 39
80. R. Hoshyar, S.Z. Bathaie, and M. Sadeghizadeh Crocin triggers the apoptosis through increasing the Bax/Bcl-2 ratio and caspase activation in human gastric adenocarcinoma, AGS, cells DNA Cell Biol 32 2013 50 57
81. M.M. Rafi, B.C. Vastano, N. Zhu, C.T. Ho, G. Ghai, and R.T. Rosen Novel polyphenol molecule isolated from licorice root (Glycrrhiza glabra) induces apoptosis, G2/M cell cycle arrest, and Bcl-2 phosphorylation in tumor cell lines J Agric Food Chem 50 2002 677 684
82. J. Ma, N.Y. Fu, D.B. Pang, W.Y. Wu, and A.L. Xu Apoptosis induced by isoliquiritigenin in human gastric cancer MGC-803 cells Planta Med 67 2001 754 757
83. C.M. Schempp, V. Kirkin, B. Simon-Haarhaus, A. Kersten, J. Kiss, and C.C. Termeer Inhibition of tumour cell growth by hyperforin, a novel anticancer drug from St. John's wort that acts by induction of apoptosis Oncogene 21 2002 1242 1250
84. K.H. Lee, I.H. Hall, E.C. Mar, C.O. Starnes, S.A. ElGebaly, and T.G. Waddell Sesquiterpene antitumor agents: inhibitors of cellular metabolism Science 196 1977 533 536
85. A. Lancon, N. Hanet, B. Jannin, D. Delmas, J.M. Heydel, and G. Lizard Resveratrol in human hepatoma HepG2 cells: metabolism and inducibility of detoxifying enzymes Drug Metab Dispos 35 2007 699 703
86. Y. Gu, C. Qi, X. Sun, X. Ma, H. Zhang, and L. Hu Arctigenin preferentially induces tumor cell death under glucose deprivation by inhibiting cellular energy metabolism Biochem Pharmacol 84 2012 468 476
87. T. Zhan, M. Digel, E.M. Kuch, W. Stremmel, and J. Fullekrug Silybin and dehydrosilybin decrease glucose uptake by inhibiting GLUT proteins J Cell Biochem 112 2011 849 859
88. S.I. Grivennikov, F.R. Greten, and M. Karin Immunity, inflammation, and cancer Cell 140 2010 883 899
89. G. Lyss, A. Knorre, T.J. Schmidt, H.L. Pahl, and I. Merfort The anti-inflammatory sesquiterpene lactone helenalin inhibits the transcription factor NF-kappaB by directly targeting p65 J Biol Chem 273 1998 33508 33516
90. C.B. Lim, P.Y. Fu, N. Ky, H.S. Zhu, X. Feng, and J. Li NF-kappaB p65 repression by the sesquiterpene lactone, Helenalin, contributes to the induction of autophagy cell death BMC Complement Altern Med 12 2012 93
91. B.H. Kwok, B. Koh, M.I. Ndubuisi, M. Elofsson, and C.M. Crews The anti-inflammatory natural product parthenolide from the medicinal herb Feverfew directly binds to and inhibits IkappaB kinase Chem Biol 8 2001 759 766
92. E. Tedeschi, M. Menegazzi, D. Margotto, H. Suzuki, U. Forstermann, and H. Kleinert Anti-inflammatory actions of St. John's wort: inhibition of human inducible nitric-oxide synthase expression by down-regulating signal transducer and activator of transcription-1alpha (STAT-1alpha) activation J Pharmacol Exp Ther 307 2003 254 261
93. A.H. Rook, G.S. Wood, M. Duvic, E.C. Vonderheid, A. Tobia, and B. Cabana A phase II placebo-controlled study of photodynamic therapy with topical hypericin and visible light irradiation in the treatment of cutaneous T-cell lymphoma and psoriasis J Am Acad Dermatol 63 2010 984 990
94. R. Ritz, R. Daniels, S. Noell, G.C. Feigl, V. Schmidt, and A. Bornemann Hypericin for visualization of high grade gliomas: first clinical experience Eur J Surg Oncol 38 2012 352 360